false
Q2
0001180262
--12-31
Large Accelerated Filer
2024-03-15
2025-09-01
2026-08-15
0
0
0
0001180262
2020-01-01
2020-06-30
xbrli:shares
0001180262
2020-07-30
iso4217:USD
0001180262
2020-06-30
0001180262
2019-12-31
iso4217:USD
xbrli:shares
0001180262
2020-04-01
2020-06-30
0001180262
2019-04-01
2019-06-30
0001180262
2019-01-01
2019-06-30
0001180262
2018-12-31
0001180262
2019-06-30
0001180262
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
2020-01-01
2020-06-30
0001180262
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2020-01-01
2020-06-30
hlf:Segment
0001180262
2019-01-01
2019-12-31
hlf:Product
0001180262
country:CN
2020-04-01
2020-06-30
0001180262
country:CN
2019-04-01
2019-06-30
0001180262
country:CN
2020-01-01
2020-06-30
0001180262
country:CN
2019-01-01
2019-06-30
0001180262
us-gaap:OtherOperatingIncomeExpenseMember
country:MX
2019-01-01
2019-06-30
0001180262
hlf:OctoberTwoThousandAndSeventeenDutchAuctionTenderOfferMember
2020-04-01
2020-06-30
0001180262
hlf:OctoberTwoThousandAndSeventeenDutchAuctionTenderOfferMember
2019-04-01
2019-06-30
0001180262
hlf:OctoberTwoThousandAndSeventeenDutchAuctionTenderOfferMember
2020-01-01
2020-06-30
0001180262
hlf:OctoberTwoThousandAndSeventeenDutchAuctionTenderOfferMember
2019-01-01
2019-06-30
0001180262
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
2020-06-30
0001180262
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
2019-12-31
0001180262
us-gaap:OtherAssetsMember
2020-06-30
0001180262
us-gaap:OtherAssetsMember
2019-12-31
0001180262
hlf:TwoPointSixTwoFivePercentageConvertibleSeniorNotesDueTwoThousandTwentyFourMember
2020-06-30
0001180262
hlf:TwoPointSixTwoFivePercentageConvertibleSeniorNotesDueTwoThousandTwentyFourMember
2019-12-31
0001180262
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
2020-06-30
0001180262
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2020-06-30
0001180262
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2019-12-31
xbrli:pure
0001180262
hlf:TwoPointSixTwoFivePercentageConvertibleSeniorNotesDueTwoThousandTwentyFourMember
2020-01-01
2020-06-30
0001180262
hlf:TwoThousandSeventeenCreditFacilityMember
2017-02-15
0001180262
hlf:TwoThousandSeventeenTermLoanBMember
hlf:TwoThousandSeventeenCreditFacilityMember
2017-02-15
0001180262
hlf:TwoThousandSeventeenRevolvingCreditFacilityMember
hlf:TwoThousandSeventeenCreditFacilityMember
2017-02-15
0001180262
hlf:TwoThousandSeventeenRevolvingCreditFacilityMember
hlf:TwoThousandSeventeenCreditFacilityMember
2020-01-01
2020-06-30
0001180262
hlf:TwoThousandSeventeenTermLoanBMember
hlf:TwoThousandSeventeenCreditFacilityMember
2020-01-01
2020-06-30
0001180262
hlf:TwoThousandSeventeenCreditFacilityMember
2020-01-01
2020-06-30
0001180262
hlf:TwoThousandSeventeenTermLoanBMember
hlf:TwoThousandSeventeenRevolvingCreditFacilityMember
hlf:TwoThousandSeventeenCreditFacilityMember
2020-01-01
2020-06-30
0001180262
hlf:TwoThousandSeventeenRevolvingCreditFacilityMember
hlf:TwoThousandSeventeenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
hlf:TwoThousandSeventeenTermLoanBMember
hlf:TwoThousandSeventeenCreditFacilityMember
us-gaap:EurodollarMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandSeventeenTermLoanBMember
hlf:TwoThousandSeventeenCreditFacilityMember
us-gaap:BaseRateMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandSeventeenRevolvingCreditFacilityMember
hlf:TwoThousandSeventeenCreditFacilityMember
us-gaap:EurodollarMember
hlf:ScenarioLeverageRatioOneMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandSeventeenRevolvingCreditFacilityMember
hlf:TwoThousandSeventeenCreditFacilityMember
us-gaap:EurodollarMember
hlf:ScenarioLeverageRatioTwoMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandSeventeenRevolvingCreditFacilityMember
hlf:TwoThousandSeventeenCreditFacilityMember
us-gaap:BaseRateMember
hlf:ScenarioLeverageRatioOneMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandSeventeenRevolvingCreditFacilityMember
hlf:TwoThousandSeventeenCreditFacilityMember
us-gaap:BaseRateMember
hlf:ScenarioLeverageRatioTwoMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandSeventeenRevolvingCreditFacilityMember
hlf:TwoThousandSeventeenCreditFacilityMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandSeventeenCreditFacilityMember
us-gaap:FederalFundsEffectiveSwapRateMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandSeventeenCreditFacilityMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandSeventeenCreditFacilityMember
us-gaap:BaseRateMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandSeventeenTermLoanBMember
hlf:TwoThousandSeventeenCreditFacilityMember
2017-02-14
2017-02-15
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
0001180262
hlf:TwoThousandEighteenTermLoanAMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
0001180262
hlf:TwoThousandEighteenTermLoanBMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
0001180262
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
0001180262
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
hlf:TwoThousandEighteenTermLoanAMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
hlf:TwoThousandEighteenTermLoanBMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
hlf:TwoThousandTwentyFourConvertibleNotesExceedsThreeFiftyMillionMember
srt:MinimumMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
0001180262
hlf:TwoThousandEighteenTermLoanBMember
hlf:TwoThousandTwentyFourConvertibleNotesExceedsThreeFiftyMillionMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
hlf:SeniorUnsecuredNotesMember
2018-08-16
0001180262
hlf:TwoThousandSeventeenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
us-gaap:OtherNonoperatingIncomeExpenseMember
hlf:TwoThousandSeventeenCreditFacilityMember
2018-01-01
2018-12-31
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
2020-01-01
2020-06-30
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
2019-12-12
0001180262
hlf:TwoThousandEighteenTermLoanBMember
us-gaap:EurodollarMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-15
2018-08-16
0001180262
hlf:TwoThousandEighteenTermLoanBMember
us-gaap:BaseRateMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-15
2018-08-16
0001180262
hlf:TwoThousandEighteenTermLoanBMember
us-gaap:EurodollarMember
hlf:TwoThousandEighteenCreditFacilityMember
2019-12-10
2019-12-12
0001180262
hlf:TwoThousandEighteenTermLoanBMember
us-gaap:BaseRateMember
hlf:TwoThousandEighteenCreditFacilityMember
2019-12-10
2019-12-12
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2019-01-01
2019-06-30
0001180262
hlf:TwoThousandEighteenTermLoanAMember
hlf:TwoThousandEighteenCreditFacilityMember
srt:MaximumMember
hlf:SecondAmendmentMember
2020-03-19
0001180262
hlf:TwoThousandEighteenTermLoanAMember
hlf:TwoThousandEighteenCreditFacilityMember
srt:MinimumMember
2020-03-19
0001180262
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
srt:MinimumMember
2020-03-19
0001180262
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
srt:MaximumMember
hlf:SecondAmendmentMember
2020-03-19
0001180262
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2020-03-19
2020-03-19
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2020-03-19
2020-03-19
0001180262
us-gaap:EurodollarMember
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2018-08-16
2018-08-16
0001180262
us-gaap:BaseRateMember
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2018-08-16
2018-08-16
0001180262
us-gaap:EurodollarMember
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2020-03-19
2020-03-19
0001180262
us-gaap:BaseRateMember
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2020-03-19
2020-03-19
0001180262
us-gaap:EurodollarMember
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2018-08-16
2018-08-16
0001180262
us-gaap:BaseRateMember
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2018-08-16
2018-08-16
0001180262
us-gaap:EurodollarMember
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2020-03-19
2020-03-19
0001180262
us-gaap:BaseRateMember
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2020-03-19
2020-03-19
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
hlf:SecondAmendmentMember
2020-03-19
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
srt:MinimumMember
hlf:TwoThousandTwentyFourConvertibleNotesExceedsThreeFiftyMillionMember
2020-03-19
0001180262
hlf:TwoThousandEighteenTermLoanAMember
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandTwentyFourConvertibleNotesExceedsThreeFiftyMillionMember
2020-03-19
2020-03-19
0001180262
us-gaap:EurodollarMember
hlf:TwoThousandEighteenTermLoanAMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
us-gaap:BaseRateMember
hlf:TwoThousandEighteenTermLoanAMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
us-gaap:EurodollarMember
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
us-gaap:BaseRateMember
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
us-gaap:EurodollarMember
hlf:TwoThousandEighteenTermLoanBMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
us-gaap:BaseRateMember
hlf:TwoThousandEighteenTermLoanBMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
us-gaap:FederalFundsEffectiveSwapRateMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
us-gaap:LondonInterbankOfferedRateLIBORMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
us-gaap:BaseRateMember
hlf:TwoThousandEighteenCreditFacilityMember
2018-08-16
2018-08-16
0001180262
us-gaap:EurodollarMember
2018-08-16
2018-08-16
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
2020-06-30
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
2019-12-31
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
2019-01-01
2019-06-30
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandEighteenTermLoanAMember
2020-06-30
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandEighteenTermLoanBMember
2020-06-30
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandEighteenTermLoanAMember
2019-12-31
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandEighteenTermLoanBMember
2019-12-31
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
2020-06-30
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandEighteenRevolvingCreditFacilityMember
2019-12-31
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
2020-04-01
2020-06-30
0001180262
hlf:TwoThousandEighteenCreditFacilityMember
2019-04-01
2019-06-30
0001180262
us-gaap:FairValueInputsLevel2Member
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandEighteenTermLoanAMember
2020-06-30
0001180262
us-gaap:FairValueInputsLevel2Member
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandEighteenTermLoanAMember
2019-12-31
0001180262
us-gaap:FairValueInputsLevel2Member
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandEighteenTermLoanBMember
2020-06-30
0001180262
us-gaap:FairValueInputsLevel2Member
hlf:TwoThousandEighteenCreditFacilityMember
hlf:TwoThousandEighteenTermLoanBMember
2019-12-31
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
2014-02-28
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
2014-02-01
2014-02-28
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
hlf:DebtIssuanceCostsMember
2014-03-31
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
2014-03-31
0001180262
hlf:TwoPointSixTwoFivePercentageConvertibleSeniorNotesDueTwoThousandTwentyFourMember
2018-03-31
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
2018-03-01
2018-03-31
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
2018-03-31
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
hlf:RepurchaseOfTwoThousandNineteenConvertibleNotesMember
2018-03-01
2018-03-31
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
hlf:RepurchaseOfTwoThousandNineteenConvertibleNotesMember
2018-03-31
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
2019-08-15
2019-08-15
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
2019-08-15
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
2020-04-01
2020-06-30
0001180262
hlf:TwoPointZeroPercentageConvertibleSeniorNotesDueTwoThousandNineteenMember
2020-01-01
2020-06-30
0001180262
hlf:ForwardShareRepurchaseTransactionMember
2014-02-01
2014-02-28
0001180262
hlf:CappedCallMember
2014-02-28
0001180262
hlf:TwoPointSixTwoFivePercentageConvertibleSeniorNotesDueTwoThousandTwentyFourMember
2018-03-01
2018-03-31
hlf:Day
0001180262
hlf:TwoPointSixTwoFivePercentageConvertibleSeniorNotesDueTwoThousandTwentyFourMember
hlf:DebtIssuanceCostsMember
2018-03-31
0001180262
hlf:TwoPointSixTwoFivePercentageConvertibleSeniorNotesDueTwoThousandTwentyFourMember
2020-04-01
2020-06-30
0001180262
hlf:TwoPointSixTwoFivePercentageConvertibleSeniorNotesDueTwoThousandTwentyFourMember
2019-04-01
2019-06-30
0001180262
hlf:TwoPointSixTwoFivePercentageConvertibleSeniorNotesDueTwoThousandTwentyFourMember
2019-01-01
2019-06-30
0001180262
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
2020-05-31
0001180262
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
2020-05-01
2020-05-31
0001180262
srt:MaximumMember
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
2020-05-01
2020-05-31
0001180262
us-gaap:DebtInstrumentRedemptionPeriodOneMember
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
2020-01-01
2020-06-30
0001180262
us-gaap:DebtInstrumentRedemptionPeriodTwoMember
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
2020-01-01
2020-06-30
0001180262
us-gaap:DebtInstrumentRedemptionPeriodThreeMember
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
2020-01-01
2020-06-30
0001180262
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
2020-05-29
0001180262
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
hlf:DebtIssuanceCostsMember
2020-05-29
0001180262
hlf:SevenPointEightSevenFivePercentageSeniorNotesDueTwoThousandAndTwentyFiveMember
2020-04-01
2020-06-30
0001180262
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2018-08-31
0001180262
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2018-08-01
2018-08-31
0001180262
srt:MaximumMember
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2018-08-01
2018-08-31
0001180262
us-gaap:DebtInstrumentRedemptionPeriodOneMember
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2020-01-01
2020-06-30
0001180262
us-gaap:DebtInstrumentRedemptionPeriodTwoMember
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2020-01-01
2020-06-30
0001180262
us-gaap:DebtInstrumentRedemptionPeriodThreeMember
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2020-01-01
2020-06-30
0001180262
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2018-09-30
0001180262
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
hlf:DebtIssuanceCostsMember
2018-09-30
0001180262
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2020-04-01
2020-06-30
0001180262
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2019-04-01
2019-06-30
0001180262
hlf:SevenPointTwoFiveZeroPercentageSeniorNotesDueTwoThousandAndTwentySixMember
2019-01-01
2019-06-30
0001180262
us-gaap:MexicanTaxAuthorityMember
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2019-01-01
2019-12-31
0001180262
us-gaap:MexicanTaxAuthorityMember
2020-06-30
0001180262
us-gaap:MexicanTaxAuthorityMember
2020-01-01
2020-06-30
0001180262
country:BR
2020-06-30
0001180262
hlf:BrazilianICMSMember
hlf:StateOfSaoPauloMember
2016-07-31
0001180262
hlf:BrazilianICMSMember
hlf:StateOfSaoPauloMember
2017-08-31
0001180262
hlf:BrazilianICMSMember
2020-06-30
0001180262
hlf:BrazilianICMSMember
hlf:StateOfRioDeJaneiroMember
2020-06-30
0001180262
us-gaap:MinistryOfFinanceIndiaMember
2020-06-30
0001180262
us-gaap:OtherNoncurrentAssetsMember
hlf:SouthKoreanCustomsAuthorityMember
hlf:AuditPeriodJanuaryTwoThousandElevenThroughMayTwoThousandThirteenMember
2020-06-30
0001180262
us-gaap:OtherNoncurrentAssetsMember
hlf:SouthKoreanCustomsAuthorityMember
hlf:AuditPeriodMayTwoThousandThirteenThroughDecemberTwoThousandThirteenMember
2020-06-30
0001180262
hlf:USFederalTradeCommissionMember
hlf:HerbalifeInternationalOfAmericaIncMember
2020-01-01
2020-06-30
0001180262
hlf:SECAndDOJInvestigationMember
2020-01-01
2020-06-30
0001180262
hlf:SECAndDOJInvestigationMember
2020-06-30
0001180262
hlf:SECAndDOJInvestigationMember
2019-12-31
0001180262
hlf:ChinaMarketingPlanSECInvestigationMember
2019-09-27
0001180262
hlf:ChinaMarketingPlanSECInvestigationMember
2019-10-31
2019-10-31
hlf:Plaintiff
0001180262
hlf:PutativeClassPlaintiffsMember
2018-08-23
2018-08-23
0001180262
us-gaap:PendingLitigationMember
2018-08-23
2018-08-23
hlf:Country
0001180262
hlf:PrimaryReportingSegmentMember
2020-04-01
2020-06-30
0001180262
hlf:PrimaryReportingSegmentMember
2019-04-01
2019-06-30
0001180262
hlf:PrimaryReportingSegmentMember
2020-01-01
2020-06-30
0001180262
hlf:PrimaryReportingSegmentMember
2019-01-01
2019-06-30
0001180262
country:CN
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2020-04-01
2020-06-30
0001180262
country:CN
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2019-04-01
2019-06-30
0001180262
country:CN
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2020-01-01
2020-06-30
0001180262
country:CN
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2019-01-01
2019-06-30
0001180262
country:US
2020-04-01
2020-06-30
0001180262
country:US
2019-04-01
2019-06-30
0001180262
country:US
2020-01-01
2020-06-30
0001180262
country:US
2019-01-01
2019-06-30
0001180262
country:MX
2020-04-01
2020-06-30
0001180262
country:MX
2019-04-01
2019-06-30
0001180262
country:MX
2020-01-01
2020-06-30
0001180262
country:MX
2019-01-01
2019-06-30
0001180262
hlf:OthersMember
2020-04-01
2020-06-30
0001180262
hlf:OthersMember
2019-04-01
2019-06-30
0001180262
hlf:OthersMember
2020-01-01
2020-06-30
0001180262
hlf:OthersMember
2019-01-01
2019-06-30
0001180262
us-gaap:StockAppreciationRightsSARSMember
2019-12-31
0001180262
us-gaap:StockAppreciationRightsSARSMember
2020-01-01
2020-06-30
0001180262
us-gaap:StockAppreciationRightsSARSMember
2020-06-30
0001180262
us-gaap:StockAppreciationRightsSARSMember
2019-01-01
2019-12-31
0001180262
hlf:MarketConditionAwardsMember
srt:MaximumMember
2020-06-30
0001180262
hlf:MarketConditionAwardsMember
srt:MaximumMember
2019-12-31
0001180262
hlf:PerformanceConditionAwardsMember
2020-06-30
0001180262
hlf:PerformanceConditionAwardsMember
2019-12-31
0001180262
us-gaap:StockAppreciationRightsSARSMember
2020-04-01
2020-06-30
0001180262
us-gaap:StockAppreciationRightsSARSMember
2019-04-01
2019-06-30
0001180262
us-gaap:StockAppreciationRightsSARSMember
2019-01-01
2019-06-30
0001180262
us-gaap:PerformanceSharesMember
srt:MaximumMember
2020-06-30
0001180262
us-gaap:PerformanceSharesMember
srt:MaximumMember
2019-12-31
0001180262
us-gaap:PerformanceSharesMember
2020-06-30
0001180262
us-gaap:PerformanceSharesMember
2019-12-31
0001180262
us-gaap:InterestRateSwapMember
hlf:TwoThousandEighteenCreditFacilityMember
2020-03-31
0001180262
us-gaap:InterestRateSwapMember
srt:MinimumMember
hlf:TwoThousandEighteenCreditFacilityMember
2020-01-01
2020-03-31
0001180262
us-gaap:InterestRateSwapMember
srt:MaximumMember
hlf:TwoThousandEighteenCreditFacilityMember
2020-01-01
2020-03-31
0001180262
us-gaap:InterestRateSwapMember
hlf:TwoThousandEighteenCreditFacilityMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2020-03-31
0001180262
us-gaap:InterestRateSwapMember
hlf:TwoThousandEighteenCreditFacilityMember
2020-06-30
0001180262
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
2020-06-30
0001180262
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
2019-12-31
0001180262
srt:MaximumMember
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
2020-01-01
2020-06-30
0001180262
us-gaap:ForeignExchangeForwardMember
srt:MaximumMember
2020-01-01
2020-06-30
0001180262
us-gaap:ForeignExchangeForwardMember
srt:MaximumMember
2019-01-01
2019-12-31
0001180262
hlf:FreestandingDerivativesMember
2020-01-01
2020-06-30
0001180262
hlf:FreestandingDerivativesMember
2019-01-01
2019-12-31
0001180262
us-gaap:ForeignExchangeContractMember
2020-06-30
0001180262
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesAndIntercompanyManagementFeeHedgesMember
us-gaap:DesignatedAsHedgingInstrumentMember
2020-04-01
2020-06-30
0001180262
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesAndIntercompanyManagementFeeHedgesMember
us-gaap:DesignatedAsHedgingInstrumentMember
2020-01-01
2020-06-30
0001180262
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesAndIntercompanyManagementFeeHedgesMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-01-01
2019-06-30
0001180262
us-gaap:InterestRateSwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2020-04-01
2020-06-30
0001180262
us-gaap:InterestRateSwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2020-01-01
2020-06-30
0001180262
us-gaap:CostOfSalesMember
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesMember
2020-04-01
2020-06-30
0001180262
us-gaap:CostOfSalesMember
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesMember
2019-04-01
2019-06-30
0001180262
us-gaap:SellingGeneralAndAdministrativeExpensesMember
hlf:ForeignExchangeCurrencyContractsRelatingToIntercompanyManagementFeeHedgesMember
2020-04-01
2020-06-30
0001180262
us-gaap:SellingGeneralAndAdministrativeExpensesMember
hlf:ForeignExchangeCurrencyContractsRelatingToIntercompanyManagementFeeHedgesMember
2019-04-01
2019-06-30
0001180262
us-gaap:InterestExpenseMember
us-gaap:InterestRateSwapMember
2020-04-01
2020-06-30
0001180262
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesMember
us-gaap:CostOfSalesMember
2020-01-01
2020-06-30
0001180262
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesMember
us-gaap:CostOfSalesMember
2019-01-01
2019-06-30
0001180262
hlf:ForeignExchangeCurrencyContractsRelatingToIntercompanyManagementFeeHedgesMember
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2020-01-01
2020-06-30
0001180262
hlf:ForeignExchangeCurrencyContractsRelatingToIntercompanyManagementFeeHedgesMember
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2019-01-01
2019-06-30
0001180262
us-gaap:InterestRateSwapMember
us-gaap:InterestExpenseMember
2020-01-01
2020-06-30
0001180262
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2020-04-01
2020-06-30
0001180262
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2019-04-01
2019-06-30
0001180262
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2020-01-01
2020-06-30
0001180262
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2019-01-01
2019-06-30
0001180262
us-gaap:CommonStockMember
2020-03-31
0001180262
us-gaap:TreasuryStockMember
2020-03-31
0001180262
us-gaap:AdditionalPaidInCapitalMember
2020-03-31
0001180262
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-03-31
0001180262
us-gaap:RetainedEarningsMember
2020-03-31
0001180262
2020-03-31
0001180262
us-gaap:AdditionalPaidInCapitalMember
2020-04-01
2020-06-30
0001180262
us-gaap:RetainedEarningsMember
2020-04-01
2020-06-30
0001180262
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-04-01
2020-06-30
0001180262
us-gaap:CommonStockMember
2020-06-30
0001180262
us-gaap:TreasuryStockMember
2020-06-30
0001180262
us-gaap:AdditionalPaidInCapitalMember
2020-06-30
0001180262
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-06-30
0001180262
us-gaap:RetainedEarningsMember
2020-06-30
0001180262
us-gaap:CommonStockMember
2019-03-31
0001180262
us-gaap:TreasuryStockMember
2019-03-31
0001180262
us-gaap:AdditionalPaidInCapitalMember
2019-03-31
0001180262
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-03-31
0001180262
us-gaap:RetainedEarningsMember
2019-03-31
0001180262
2019-03-31
0001180262
us-gaap:AdditionalPaidInCapitalMember
2019-04-01
2019-06-30
0001180262
us-gaap:RetainedEarningsMember
2019-04-01
2019-06-30
0001180262
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-04-01
2019-06-30
0001180262
us-gaap:CommonStockMember
2019-06-30
0001180262
us-gaap:TreasuryStockMember
2019-06-30
0001180262
us-gaap:AdditionalPaidInCapitalMember
2019-06-30
0001180262
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-06-30
0001180262
us-gaap:RetainedEarningsMember
2019-06-30
0001180262
us-gaap:CommonStockMember
2019-12-31
0001180262
us-gaap:TreasuryStockMember
2019-12-31
0001180262
us-gaap:AdditionalPaidInCapitalMember
2019-12-31
0001180262
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-12-31
0001180262
us-gaap:RetainedEarningsMember
2019-12-31
0001180262
us-gaap:AdditionalPaidInCapitalMember
2020-01-01
2020-06-30
0001180262
us-gaap:RetainedEarningsMember
2020-01-01
2020-06-30
0001180262
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-01-01
2020-06-30
0001180262
us-gaap:CommonStockMember
2018-12-31
0001180262
us-gaap:TreasuryStockMember
2018-12-31
0001180262
us-gaap:AdditionalPaidInCapitalMember
2018-12-31
0001180262
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-31
0001180262
us-gaap:RetainedEarningsMember
2018-12-31
0001180262
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
2019-06-30
0001180262
us-gaap:RetainedEarningsMember
2019-01-01
2019-06-30
0001180262
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-06-30
0001180262
2018-10-30
0001180262
2018-10-30
2018-10-30
0001180262
hlf:ForwardShareRepurchaseTransactionMember
2020-01-01
2020-06-30
0001180262
hlf:ForwardShareRepurchaseTransactionMember
2020-06-29
2020-06-30
0001180262
hlf:ForwardShareRepurchaseTransactionMember
2020-06-30
0001180262
hlf:ForwardShareRepurchaseTransactionMember
2014-01-01
2014-03-31
0001180262
hlf:ForwardShareRepurchaseTransactionMember
2014-03-31
0001180262
hlf:ForwardShareRepurchaseTransactionMember
2019-04-01
2019-06-30
0001180262
hlf:ForwardShareRepurchaseTransactionMember
2019-01-01
2019-06-30
0001180262
hlf:OpenMarketRepurchasePlanMember
2020-01-01
2020-06-30
0001180262
hlf:OpenMarketRepurchasePlanMember
2019-01-01
2019-06-30
0001180262
hlf:CappedCallMember
hlf:ConvertibleNotesMember
2014-02-28
0001180262
hlf:CappedCallMember
2014-02-01
2014-02-28
0001180262
hlf:CappedCallMember
2014-01-01
2014-03-31
0001180262
hlf:CappedCallMember
2018-01-01
2018-12-31
0001180262
us-gaap:AccumulatedTranslationAdjustmentMember
2020-03-31
0001180262
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2020-03-31
0001180262
us-gaap:AccumulatedTranslationAdjustmentMember
2019-03-31
0001180262
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2019-03-31
0001180262
us-gaap:AccumulatedTranslationAdjustmentMember
2020-04-01
2020-06-30
0001180262
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2020-04-01
2020-06-30
0001180262
us-gaap:AccumulatedTranslationAdjustmentMember
2019-04-01
2019-06-30
0001180262
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2019-04-01
2019-06-30
0001180262
us-gaap:AccumulatedTranslationAdjustmentMember
2020-06-30
0001180262
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2020-06-30
0001180262
us-gaap:AccumulatedTranslationAdjustmentMember
2019-06-30
0001180262
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2019-06-30
0001180262
us-gaap:AccumulatedTranslationAdjustmentMember
2019-12-31
0001180262
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2019-12-31
0001180262
us-gaap:AccumulatedTranslationAdjustmentMember
2018-12-31
0001180262
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2018-12-31
0001180262
us-gaap:AccumulatedTranslationAdjustmentMember
2020-01-01
2020-06-30
0001180262
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2020-01-01
2020-06-30
0001180262
us-gaap:AccumulatedTranslationAdjustmentMember
2019-01-01
2019-06-30
0001180262
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2019-01-01
2019-06-30
0001180262
us-gaap:DesignatedAsHedgingInstrumentMember
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesAndIntercompanyManagementFeeHedgesMember
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
us-gaap:FairValueInputsLevel2Member
2020-06-30
0001180262
us-gaap:DesignatedAsHedgingInstrumentMember
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesAndIntercompanyManagementFeeHedgesMember
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
us-gaap:FairValueInputsLevel2Member
2019-12-31
0001180262
us-gaap:NondesignatedMember
us-gaap:ForeignExchangeContractMember
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
us-gaap:FairValueInputsLevel2Member
2020-06-30
0001180262
us-gaap:NondesignatedMember
us-gaap:ForeignExchangeContractMember
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
us-gaap:FairValueInputsLevel2Member
2019-12-31
0001180262
us-gaap:FairValueInputsLevel2Member
2020-06-30
0001180262
us-gaap:FairValueInputsLevel2Member
2019-12-31
0001180262
us-gaap:DesignatedAsHedgingInstrumentMember
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesAndIntercompanyManagementFeeHedgesMember
us-gaap:OtherCurrentLiabilitiesMember
us-gaap:FairValueInputsLevel2Member
2020-06-30
0001180262
us-gaap:DesignatedAsHedgingInstrumentMember
hlf:ForeignExchangeCurrencyContractsRelatingToInventoryHedgesAndIntercompanyManagementFeeHedgesMember
us-gaap:OtherCurrentLiabilitiesMember
us-gaap:FairValueInputsLevel2Member
2019-12-31
0001180262
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:InterestRateSwapMember
us-gaap:OtherCurrentLiabilitiesMember
us-gaap:FairValueInputsLevel2Member
2020-06-30
0001180262
us-gaap:NondesignatedMember
us-gaap:ForeignExchangeContractMember
us-gaap:OtherCurrentLiabilitiesMember
us-gaap:FairValueInputsLevel2Member
2020-06-30
0001180262
us-gaap:NondesignatedMember
us-gaap:ForeignExchangeContractMember
us-gaap:OtherCurrentLiabilitiesMember
us-gaap:FairValueInputsLevel2Member
2019-12-31
0001180262
us-gaap:ForeignExchangeContractMember
2019-12-31
0001180262
us-gaap:InterestRateSwapMember
2020-06-30
0001180262
us-gaap:SubsequentEventMember
2020-07-13
0001180262
srt:MinimumMember
us-gaap:SubsequentEventMember
2020-07-13
0001180262
srt:MaximumMember
us-gaap:SubsequentEventMember
2020-07-13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2020
OR
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 1-32381
HERBALIFE NUTRITION LTD.
(Exact name of registrant as specified in its charter)
Cayman Islands |
98-0377871 |
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
P.O. Box 309GT
Ugland House, South Church Street
Grand Cayman, Cayman Islands |
KY1-1106 |
(Address of principal executive offices) |
(Zip code) |
(213) 745-0500
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class: |
Trading Symbol(s): |
Name of each exchange on which registered: |
Common Shares, par value $0.0005 per share |
HLF |
New York Stock Exchange |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
☒ |
Accelerated filer |
☐ |
|
|
|
|
Non-accelerated filer |
☐ |
Smaller reporting company |
☐ |
|
|
|
|
Emerging growth company |
☐ |
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Number of shares of registrant’s common shares outstanding as of July 30, 2020 was 147,555,552.
TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION
Item 1. |
Financial Statements |
HERBALIFE NUTRITION LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
June 30,
2020 |
|
|
December 31,
2019 |
|
|
|
(in millions, except share and par value amounts) |
|
ASSETS |
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
1,740.0 |
|
|
$ |
839.4 |
|
Receivables, net of allowance for doubtful accounts |
|
|
105.9 |
|
|
|
79.7 |
|
Inventories |
|
|
421.8 |
|
|
|
436.2 |
|
Prepaid expenses and other current assets |
|
|
140.2 |
|
|
|
132.9 |
|
Total current assets |
|
|
2,407.9 |
|
|
|
1,488.2 |
|
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization |
|
|
366.0 |
|
|
|
371.5 |
|
Operating lease right-of-use assets |
|
|
183.4 |
|
|
|
189.5 |
|
Marketing-related intangibles and other intangible assets, net |
|
|
310.1 |
|
|
|
310.1 |
|
Goodwill |
|
|
86.8 |
|
|
|
91.5 |
|
Other assets |
|
|
213.2 |
|
|
|
227.8 |
|
Total assets |
|
$ |
3,567.4 |
|
|
$ |
2,678.6 |
|
LIABILITIES AND SHAREHOLDERS’ DEFICIT |
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
87.2 |
|
|
$ |
81.6 |
|
Royalty overrides |
|
|
309.7 |
|
|
|
294.1 |
|
Current portion of long-term debt |
|
|
23.0 |
|
|
|
24.1 |
|
Other current liabilities |
|
|
683.1 |
|
|
|
564.6 |
|
Total current liabilities |
|
|
1,103.0 |
|
|
|
964.4 |
|
Long-term debt, net of current portion |
|
|
2,404.1 |
|
|
|
1,778.9 |
|
Non-current operating lease liabilities |
|
|
168.1 |
|
|
|
169.9 |
|
Other non-current liabilities |
|
|
157.0 |
|
|
|
155.4 |
|
Total liabilities |
|
|
3,832.2 |
|
|
|
3,068.6 |
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Shareholders’ deficit: |
|
|
|
|
|
|
|
|
Common shares, $0.0005 par value; 2.0 billion shares authorized; 137.5 million (2020) and 137.4 million (2019) shares outstanding |
|
|
0.1 |
|
|
|
0.1 |
|
|
Paid-in capital in excess of par value |
|
|
380.7 |
|
|
|
366.6 |
|
Accumulated other comprehensive loss |
|
|
(246.1 |
) |
|
|
(212.5 |
) |
Accumulated deficit |
|
|
(70.6 |
) |
|
|
(215.3 |
) |
Treasury stock, at cost, 10.0 million (2020) and 10.0 million (2019) shares |
|
|
(328.9 |
) |
|
|
(328.9 |
) |
Total shareholders’ deficit |
|
|
(264.8 |
) |
|
|
(390.0 |
) |
Total liabilities and shareholders’ deficit |
|
$ |
3,567.4 |
|
|
$ |
2,678.6 |
|
See the accompanying notes to unaudited condensed consolidated financial statements.
3
HERBALIFE NUTRITION LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30,
2020 |
|
|
June 30,
2019 |
|
|
June 30,
2020 |
|
|
June 30,
2019 |
|
|
|
(in millions, except per share amounts) |
|
Net sales |
|
$ |
1,346.9 |
|
|
$ |
1,240.1 |
|
|
$ |
2,609.3 |
|
|
$ |
2,412.3 |
|
Cost of sales |
|
|
272.8 |
|
|
|
243.2 |
|
|
|
518.5 |
|
|
|
484.8 |
|
Gross profit |
|
|
1,074.1 |
|
|
|
996.9 |
|
|
|
2,090.8 |
|
|
|
1,927.5 |
|
Royalty overrides |
|
|
406.9 |
|
|
|
366.8 |
|
|
|
788.1 |
|
|
|
726.3 |
|
Selling, general, and administrative expenses |
|
|
480.8 |
|
|
|
477.0 |
|
|
|
1,029.8 |
|
|
|
912.4 |
|
Other operating income |
|
|
(3.3 |
) |
|
|
— |
|
|
|
(12.4 |
) |
|
|
(27.3 |
) |
Operating income |
|
|
189.7 |
|
|
|
153.1 |
|
|
|
285.3 |
|
|
|
316.1 |
|
Interest expense, net |
|
|
28.8 |
|
|
|
36.3 |
|
|
|
53.8 |
|
|
|
72.4 |
|
Other income, net |
|
|
— |
|
|
|
(5.9 |
) |
|
|
— |
|
|
|
(14.4 |
) |
Income before income taxes |
|
|
160.9 |
|
|
|
122.7 |
|
|
|
231.5 |
|
|
|
258.1 |
|
Income taxes |
|
|
45.8 |
|
|
|
46.2 |
|
|
|
70.8 |
|
|
|
85.3 |
|
Net income |
|
$ |
115.1 |
|
|
$ |
76.5 |
|
|
$ |
160.7 |
|
|
$ |
172.8 |
|
Earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.84 |
|
|
$ |
0.56 |
|
|
$ |
1.17 |
|
|
$ |
1.26 |
|
Diluted |
|
$ |
0.82 |
|
|
$ |
0.54 |
|
|
$ |
1.15 |
|
|
$ |
1.20 |
|
Weighted-average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
137.9 |
|
|
|
137.4 |
|
|
|
137.9 |
|
|
|
137.2 |
|
Diluted |
|
|
140.1 |
|
|
|
142.4 |
|
|
|
140.1 |
|
|
|
144.2 |
|
See the accompanying notes to unaudited condensed consolidated financial statements.
4
HERBALIFE NUTRITION LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30,
2020 |
|
|
June 30,
2019 |
|
|
June 30,
2020 |
|
|
June 30,
2019 |
|
|
|
(in millions) |
|
Net income |
|
$ |
115.1 |
|
|
$ |
76.5 |
|
|
$ |
160.7 |
|
|
$ |
172.8 |
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment, net of income taxes of $(2.3) and $(1.5) for the three months ended June 30, 2020 and 2019, respectively, and $(4.8) and $(1.0) for the six months ended June 30, 2020 and 2019, respectively |
|
|
17.2 |
|
|
|
(1.8 |
) |
|
|
(39.9 |
) |
|
|
5.3 |
|
|
Unrealized (loss) gain on derivatives, net of income taxes of $— for both the three months ended June 30, 2020 and 2019, respectively, and $(0.3) and $— for the six months ended June 30, 2020 and 2019, respectively |
|
|
(0.3 |
) |
|
|
(0.5 |
) |
|
|
6.3 |
|
|
|
(1.9 |
) |
Total other comprehensive income (loss) |
|
|
16.9 |
|
|
|
(2.3 |
) |
|
|
(33.6 |
) |
|
|
3.4 |
|
Total comprehensive income |
|
$ |
132.0 |
|
|
$ |
74.2 |
|
|
$ |
127.1 |
|
|
$ |
176.2 |
|
See the accompanying notes to unaudited condensed consolidated financial statements.
5
HERBALIFE NUTRITION LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
Six Months Ended |
|
|
|
June 30,
2020 |
|
|
June 30,
2019 |
|
|
|
(in millions) |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
160.7 |
|
|
$ |
172.8 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
49.9 |
|
|
|
49.0 |
|
Share-based compensation expenses |
|
|
22.5 |
|
|
|
20.5 |
|
Non-cash interest expense |
|
|
12.8 |
|
|
|
27.6 |
|
Deferred income taxes |
|
|
9.7 |
|
|
|
3.9 |
|
Inventory write-downs |
|
|
8.1 |
|
|
|
11.7 |
|
Foreign exchange transaction loss |
|
|
7.1 |
|
|
|
5.0 |
|
Other |
|
|
1.2 |
|
|
|
(11.8 |
) |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Receivables |
|
|
(33.7 |
) |
|
|
(29.0 |
) |
Inventories |
|
|
(19.4 |
) |
|
|
(50.8 |
) |
Prepaid expenses and other current assets |
|
|
(18.4 |
) |
|
|
14.6 |
|
Accounts payable |
|
|
9.5 |
|
|
|
(0.3 |
) |
Royalty overrides |
|
|
29.5 |
|
|
|
(16.6 |
) |
Other current liabilities |
|
|
140.3 |
|
|
|
(81.3 |
) |
Other |
|
|
5.2 |
|
|
|
(0.5 |
) |
Net cash provided by operating activities |
|
|
385.0 |
|
|
|
114.8 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchases of property, plant, and equipment |
|
|
(49.6 |
) |
|
|
(51.7 |
) |
Other |
|
|
0.2 |
|
|
|
— |
|
Net cash used in investing activities |
|
|
(49.4 |
) |
|
|
(51.7 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Borrowings from senior secured credit facility, net of discount |
|
|
30.2 |
|
|
|
— |
|
Principal payments on senior secured credit facility and other debt |
|
|
(10.6 |
) |
|
|
(10.2 |
) |
Proceeds from senior notes |
|
|
600.0 |
|
|
|
— |
|
Debt issuance costs |
|
|
(6.8 |
) |
|
|
— |
|
Share repurchases |
|
|
(26.0 |
) |
|
|
(9.0 |
) |
Other |
|
|
1.6 |
|
|
|
1.5 |
|
Net cash provided by (used in) financing activities |
|
|
588.4 |
|
|
|
(17.7 |
) |
Effect of exchange rate changes on cash, cash equivalents, and restricted cash |
|
|
(23.4 |
) |
|
|
1.9 |
|
Net change in cash, cash equivalents, and restricted cash |
|
|
900.6 |
|
|
|
47.3 |
|
Cash, cash equivalents, and restricted cash, beginning of period |
|
|
847.5 |
|
|
|
1,215.0 |
|
Cash, cash equivalents, and restricted cash, end of period |
|
$ |
1,748.1 |
|
|
$ |
1,262.3 |
|
See the accompanying notes to unaudited condensed consolidated financial statements.
6
HERBALIFE NUTRITION LTD. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Organization
Herbalife Nutrition Ltd., a Cayman Islands exempted company with limited liability, was incorporated on April 4, 2002. Herbalife Nutrition Ltd. (and together with its subsidiaries, the “Company” or “Herbalife”) is a global nutrition company that sells weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition products to and through a network of independent members, or Members. In China, the Company sells its products to and through independent service providers, sales representatives, and sales officers to customers and preferred customers, as well as through Company-operated retail platforms when necessary. The Company sells its products in six geographic regions: North America; Mexico; South and Central America; EMEA, which consists of Europe, the Middle East, and Africa; Asia Pacific (excluding China); and China.
2. Significant Accounting Policies
Basis of Presentation
The unaudited condensed consolidated interim financial information of the Company has been prepared in accordance with Article 10 of the Securities and Exchange Commission’s, or the SEC, Regulation S-X. Accordingly, as permitted by Article 10 of the SEC’s Regulation S-X, it does not include all of the information required by generally accepted accounting principles in the U.S., or U.S. GAAP, for complete financial statements. The condensed consolidated balance sheet as of December 31, 2019 was derived from the audited financial statements at that date and does not include all the disclosures required by U.S. GAAP, as permitted by Article 10 of the SEC’s Regulation S-X. The Company’s unaudited condensed consolidated financial statements as of June 30, 2020 and for the three and six months ended June 30, 2020 and 2019 include Herbalife Nutrition Ltd. and all of its direct and indirect subsidiaries. In the opinion of management, the accompanying financial information contains all adjustments, consisting of normal recurring adjustments, necessary to present fairly the Company’s unaudited condensed consolidated financial statements as of June 30, 2020 and for the three and six months ended June 30, 2020 and 2019. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, or the 2019 10-K. Operating results for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.
Recently Adopted Pronouncements
In June 2016, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This ASU changes the impairment model for most financial assets, requiring the use of an expected loss model which requires entities to estimate the lifetime expected credit loss on financial assets measured at amortized cost. Such credit losses will be recorded as an allowance to offset the amortized cost of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. In addition, credit losses relating to available-for-sale debt securities will now be recorded through an allowance for credit losses rather than as a direct write-down to the security. The amendments in this update are effective for reporting periods beginning after December 15, 2019, with early adoption permitted for reporting periods beginning after December 15, 2018. The adoption of this guidance during the first quarter of 2020 did not have a material impact on the Company’s condensed consolidated financial statements.
In January 2017, the FASB issued ASU No. 2017-04, Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This ASU simplifies the test for goodwill impairment by removing Step 2 from the goodwill impairment test. Companies will now perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value not to exceed the total amount of goodwill allocated to that reporting unit. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The amendments in this update are effective for goodwill impairment tests in fiscal years beginning after December 15, 2019, with early adoption permitted for goodwill impairment tests performed after January 1, 2017. The adoption of this guidance during the first quarter of 2020 did not have a material impact on the Company’s condensed consolidated financial statements.
7
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modifies the disclosure requirements on fair value measurements in Topic 820 based on the consideration of costs and benefits to promote the appropriate exercise and discretion by entities when considering fair value measurement disclosures and to clarify that materiality is an appropriate consideration of entities and their auditors when evaluating disclosure requirements. The amendments in this update are effective for reporting periods beginning after December 15, 2019, with early adoption permitted. The adoption of this guidance during the first quarter of 2020 did not have a material impact on the Company’s condensed consolidated financial statements.
In August 2018, the FASB issued ASU No. 2018-15, Intangibles — Goodwill and Other — Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. This ASU clarifies the accounting for implementation costs of a hosting arrangement that is a service contract and aligns that accounting, regardless of whether the arrangement conveys a license to the hosted software. The amendments in this update are effective for reporting periods beginning after December 15, 2019, with early adoption permitted. The Company adopted the guidance with an initial application date of January 1, 2020 with prospective application to implementation costs incurred after January 1, 2020. The adoption of this guidance did not have a material impact on the Company’s condensed consolidated financial statements.
In November 2019, the FASB issued ASU No. 2019-08, Compensation—Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Codification Improvements—Share-Based Consideration Payable to a Customer. This ASU clarifies the accounting for measuring share-based payment awards granted to a customer. The amendments in this update are effective for reporting periods beginning after December 15, 2019, with early adoption permitted. The adoption of this guidance during the first quarter of 2020 did not have a material impact on the Company’s condensed consolidated financial statements.
In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. The amendments in this update are effective as of March 12, 2020 through December 31, 2022. The adoption of this guidance during the first quarter of 2020 did not have a material impact on the Company’s condensed consolidated financial statements.
New Accounting Pronouncements
In August 2018, the FASB issued ASU No. 2018-14, Compensation — Retirement Benefits — Defined Benefit Plans — General (Subtopic 715-20): Disclosure Framework — Changes to the Disclosure Requirements for Defined Benefit Plans. This ASU removes disclosures that are no longer considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. The amendments in this update are effective for reporting periods beginning after December 15, 2020, with early adoption permitted. The Company is evaluating the potential impact of this adoption on its condensed consolidated financial statements.
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This ASU simplifies the accounting for income taxes by eliminating some exceptions to the general approach in ASC Topic 740, Income Taxes, and clarifies certain aspects of the existing guidance to promote more consistent application, among other things. The amendments in this update are effective for reporting periods beginning after December 15, 2020, with early adoption permitted. The Company is evaluating the potential impact of this adoption on its condensed consolidated financial statements.
Revenue Recognition
The Company’s net sales consist of product sales. In general, the Company's performance obligation is to transfer its products to its Members. The Company generally recognizes revenue when product is delivered to its Members. For China independent service providers and for third-party importers utilized in certain other countries where sales historically have not been material, the Company recognizes revenue based on the Company’s estimate of when the service provider or third-party importer sells the products because the Company is deemed to be the principal party of these product sales due to the additional selling and operating requirements relating to pricing of products, conducting business with physical locations, and other selling and marketing activities required of the service providers and third-party importers.
The Company’s Members, excluding its China independent service providers, may receive distributor allowances, which are comprised of discounts, rebates, and wholesale commission payments from the Company. Distributor allowances resulting from the Company’s sales of its products to its Members are recorded against net sales because the distributor allowances represent discounts from the suggested retail price.
8
The Company compensates its sales leader Members with royalty overrides for services rendered, relating to the development, retention, and management of their sales organizations. Royalty overrides are payable based on achieved sales volume. Royalty overrides are classified as an operating expense reflecting the services provided to the Company. The Company compensates its China independent service providers and third-party importers utilized in certain other countries for providing marketing, selling, and customer support services. As the Company is the principal party of the product sales as described above, the service fees payable to China independent service providers and the compensation received by third-party importers for the services they provide, which represents the discount provided to them, are recorded in selling, general, and administrative expenses within the Company’s condensed consolidated statements of income.
The Company recognizes revenue when it delivers products to its United States Members; distributor allowances, inclusive of discounts and wholesale commissions, are recorded as a reduction to net sales; and royalty overrides are classified as an operating expense.
Shipping and handling services relating to product sales are recognized as fulfillment activities on the Company’s performance obligation to transfer products and are therefore recorded within net sales as part of product sales and are not considered as separate revenues. Shipping and handling costs paid by the Company are included in cost of sales.
The Company presents sales taxes collected from customers on a net basis.
The Company generally receives the net sales price in cash or through credit card payments at the point of sale. Accounts receivable consist principally of credit card receivables arising from the sale of products to the Company’s Members, and its collection risk is reduced due to geographic dispersion. Credit card receivables were $88.2 million and $56.0 million as of June 30, 2020 and December 31, 2019, respectively. Substantially all credit card receivables were current as of June 30, 2020 and December 31, 2019. The Company recorded $0.9 million and $0.5 million during the three months ended June 30, 2020 and 2019, respectively, and $1.3 million and $1.1 million during the six months ended June 30, 2020 and 2019, respectively, in bad-debt expense related to allowances for the Company’s receivables. As of both June 30, 2020 and December 31, 2019, the Company’s allowance for doubtful accounts was $2.5 million. As of June 30, 2020 and December 31, 2019, the majority of the Company’s total outstanding accounts receivable were current.
The Company records advance sales deposits when payment is received but revenue has not yet been recognized. In the majority of the Company’s markets, advance sales deposits are generally recorded to income when the product is delivered to its Members. Additionally, advance sales deposits also include deferred revenues due to the timing of revenue recognition for products sold through China independent service providers. The estimated deferral period for advance sales deposits is generally within one week. During the six months ended June 30, 2020, the Company recognized substantially all of the revenues that were included within advance sales deposits as of December 31, 2019 and any remaining such balance was not material as of June 30, 2020. Advance sales deposits are included in Other current liabilities on the Company’s condensed consolidated balance sheets. See Note 13, Detail of Certain Balance Sheet Accounts, for further information.
In general, if a Member returns product to the Company on a timely basis, they may obtain replacement product from the Company for such returned products. In addition, in general the Company maintains a buyback program pursuant to which it will repurchase products sold to a Member who has decided to leave the business. Allowances for product returns, primarily in connection with the Company’s buyback program, are provided at the time the sale is recorded. This accrual is based upon historical return rates for each country and the relevant return pattern, which reflects anticipated returns to be received over a period of up to 12 months following the original sale. Allowances for product returns were $4.0 million and $4.7 million as of June 30, 2020 and December 31, 2019, respectively.
The Company’s products are grouped in five principal categories: weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items. However, the effect of economic factors on the nature, amount, timing, and uncertainty of revenue recognition and cash flows are similar among all five product categories. The Company defines its operating segments through six geographic regions. The effect of economic factors on the nature, amount, timing, and uncertainty of revenue recognition and cash flows are similar among the geographic regions within the Company’s Primary Reporting Segment. See Note 6, Segment Information, for further information on the Company’s reportable segments and the Company’s presentation of disaggregated revenue by reportable segment.
9
Distributor Compensation – U.S.
In the U.S., distributor compensation, including Royalty overrides, is capped if the Company does not meet an annual requirement as described in the consent order discussed in more detail in Note 5, Contingencies. On a periodic basis, the Company evaluates if this requirement will be achieved by year end to determine if a cap on distributor compensation will be required, and then determines the appropriate amount of distributor compensation expense, which may vary in each reporting period. As of June 30, 2020, the Company believes that the cap to distributor compensation will not be applicable for the current year.
Other Operating Income
To encourage local investment and operations, governments in various China provinces conduct grant programs. The Company applied for and received several such grants in China. Government grants are recorded into income when a legal right to the grant exists, there is a reasonable assurance that the grant proceeds will be received, and the substantive conditions under which the grants were provided have been met. Generally, these substantive conditions are the Company maintaining operations and paying certain taxes in the relevant province and obtaining government approval by completing an annual application process. The Company believes the continuing obligation with respect to the funds is a general requirement that they are used only for its business in China. The Company recognized government grant income related to its regional headquarters and distribution centers within China of approximately $3.3 million during the three months ended June 30, 2020 and approximately $12.4 million and $21.3 million during the six months ended June 30, 2020 and 2019, respectively, in other operating income within its condensed consolidated statements of income. The Company did not recognize any government grant income related to its regional headquarters and distribution centers within China during the three months ended June 30, 2019. The Company intends to continue applying for government grants in China when programs are available; however, there is no assurance that the Company will receive grants in future periods.
During the six months ended June 30, 2019, the Company also recognized $6.0 million in other operating income related to the finalization of insurance recoveries in connection with the flooding at one of its warehouses in Mexico during September 2017, which damaged certain of the Company’s inventory stored within the warehouse. See Note 7, Contingencies, to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, or the 2018 10-K, for further discussion.
Other Income, Net
During the three months ended June 30, 2020, the Company did not recognize any other income, net. During the three months ended June 30, 2019, the Company recognized a gain of $5.9 million on the revaluation of the non-transferable contractual contingent value right, or CVR, provided for each share tendered in the October 2017 modified Dutch auction tender offer (See Note 8, Shareholders’ Deficit, to the Consolidated Financial Statements included in the Company’s 2019 10-K for further information on the CVR) in other income, net within its condensed consolidated statements of income.
During the six months ended June 30, 2020, the Company did not recognize any other income, net. During the six months ended June 30, 2019, the Company recognized a gain of $14.4 million on the revaluation of the CVR in other income, net within its condensed consolidated statements of income.
This non-cash income is included as a non-cash adjustment to net income in the Company’s cash flows from operating activities within its condensed consolidated statements of cash flows.
Restricted Cash
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Company’s condensed consolidated balance sheets that sum to the total of the same such amounts shown in the Company’s condensed consolidated statements of cash flows:
|
|
June 30,
2020 |
|
|
December 31,
2019 |
|
|
|
(in millions) |
|
Cash and cash equivalents |
|
$ |
1,740.0 |
|
|
$ |
839.4 |
|
Restricted cash included in Prepaid expenses and other current assets |
|
|
2.5 |
|
|
|
2.5 |
|
Restricted cash included in Other assets |
|
|
5.6 |
|
|
|
5.6 |
|
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows |
|
$ |
1,748.1 |
|
|
$ |
847.5 |
|
10
The majority of the Company’s consolidated restricted cash is held by certain of its foreign entities and consists of cash deposits that are required due to the business operating requirements in those jurisdictions.
COVID-19 Pandemic
During March 2020, the World Health Organization characterized the outbreak of coronavirus disease 2019, or COVID-19, as a pandemic. In response to the spread of COVID-19, certain government agencies and the Company itself have mandated various measures and recommended others, in each to protect the public and the Company’s employees, which have disrupted certain areas of the Company’s business including, but not limited to, distribution and selling activities. Despite the pandemic having a negative impact in certain of the Company’s markets, the Company’s consolidated net sales was higher for both the three and six months ended June 30, 2020 as compared to the same periods in 2019 and, exclusive of the impact of the May 2020 offering of senior secured notes its cash and cash equivalents as of June 30, 2020 increased as compared to December 31, 2019. The ultimate extent and magnitude of the impact of COVID-19 is not known and could have a material adverse impact to the Company’s business and future financial condition and results of operations. Management has been and continues to actively monitor the impact of COVID-19 generally and on the Company.
The Company’s condensed consolidated financial statements presented herein reflect the latest estimates and assumptions made by management that affect the reported amounts of assets and liabilities and related disclosures as of the date of the condensed consolidated financial statements and reported amounts of revenue and expenses during the reporting periods presented. The Company believes it has used reasonable estimates and assumptions to assess the fair values of its goodwill, marketing-related intangible assets, and long-lived assets; assessment of the annual effective tax rate; valuation of deferred income taxes; and the allowance for doubtful accounts. After reviewing historical and forward-looking information, the Company determined there were no impairments required relating to its goodwill, marketing-related intangible assets, and long-lived assets during the three and six months ended June 30, 2020.
3. Inventories
Inventories consist primarily of finished goods available for resale. Inventories are stated at lower of cost (primarily on the first-in, first-out basis) and net realizable value.
The following are the major classes of inventory:
|
|
June 30,
2020 |
|
|
December 31,
2019 |
|
|
|
(in millions) |
|
Raw materials |
|
$ |
67.8 |
|
|
$ |
48.7 |
|
Work in process |
|
|
6.2 |
|
|
|
6.6 |
|
Finished goods |
|
|
347.8 |
|
|
|
380.9 |
|
Total |
|
$ |
421.8 |
|
|
$ |
436.2 |
|
4. Long-Term Debt
Long-term debt consists of the following:
|
|
June 30,
2020 |
|
|
December 31,
2019 |
|
|
|
(in millions) |
|
Borrowings under senior secured credit facility, carrying value |
|
$ |
986.0 |
|
|
$ |
965.3 |
|
2.625% convertible senior notes due 2024, carrying value of liability component |
|
|
448.8 |
|
|
|
437.4 |
|
7.875% senior notes due 2025, carrying value |
|
|
592.3 |
|
|
|
— |
|
7.250% senior notes due 2026, carrying value |
|
|
395.6 |
|
|
|
395.3 |
|
Other |
|
|
4.4 |
|
|
|
5.0 |
|
Total |
|
|
2,427.1 |
|
|
|
1,803.0 |
|
Less: current portion |
|
|
23.0 |
|
|
|
24.1 |
|
Long-term portion |
|
$ |
2,404.1 |
|
|
$ |
1,778.9 |
|
11
Senior Secured Credit Facility
On February 15, 2017, the Company entered into a $1,450.0 million senior secured credit facility, or the 2017 Credit Facility, consisting of a $1,300.0 million term loan B, or the 2017 Term Loan B, and a $150.0 million revolving credit facility, or the 2017 Revolving Credit Facility, with a syndicate of financial institutions as lenders. The 2017 Revolving Credit Facility was to mature on February 15, 2022 and the 2017 Term Loan B was to mature on February 15, 2023. The 2017 Credit Facility was amended, effective March 16, 2018, to make certain technical amendments in connection with the offering of the 2024 Convertible Notes, as defined below. The Company terminated the 2017 Credit Facility on August 16, 2018 and the $1,178.1 million outstanding was repaid in full. Prior to its termination, the 2017 Term Loan B most recently bore interest at either the eurocurrency rate plus a margin of 5.50% or the base rate plus a margin of 4.50%, and the 2017 Revolving Credit Facility most recently bore interest at either the eurocurrency rate plus a margin of either 4.50% or 4.75% or the base rate plus a margin of either 3.50% or 3.75%, based on the Company’s consolidated leverage ratio. The eurocurrency rate was based on adjusted LIBOR and was subject to a floor of 0.75%. The base rate represented the highest of the Federal Funds Rate plus 0.50%, one-month adjusted LIBOR plus 1.00%, and the prime rate set by Credit Suisse, and was subject to a floor of 1.75%.
The 2017 Term Loan B was issued to the lenders at a 2% discount, or $26.0 million. The Company incurred approximately $22.6 million of debt issuance costs in connection with the 2017 Credit Facility. The debt issuance costs and the discount were recorded on the Company’s condensed consolidated balance sheet and were being amortized over the life of the 2017 Credit Facility using the effective-interest method. The Company wrote off all remaining unamortized debt issuance costs and discount related to the 2017 Credit Facility upon its termination, which is included in the loss on extinguishment as described below.
On August 16, 2018, the Company entered into a $1.25 billion senior secured credit facility, or the 2018 Credit Facility, consisting of a $250.0 million term loan A, or the 2018 Term Loan A, a $750.0 million term loan B, or the 2018 Term Loan B, and a $250.0 million revolving credit facility, or the 2018 Revolving Credit Facility, with a syndicate of financial institutions as lenders. Prior to the amendment described below, the 2018 Term Loan A and 2018 Revolving Credit Facility both were to mature on August 16, 2023. The 2018 Term Loan B matures upon the earlier of: (i) August 18, 2025; or (ii) December 15, 2023 if the outstanding principal on the 2024 Convertible Notes, as defined below, exceeds $350.0 million and the Company exceeds certain leverage ratios as of that date. All obligations under the 2018 Credit Facility are unconditionally guaranteed by certain direct and indirect wholly-owned subsidiaries of Herbalife Nutrition Ltd. and secured by the equity interests of certain of Herbalife Nutrition Ltd.’s subsidiaries and substantially all of the assets of the domestic loan parties. Also on August 16, 2018, the Company issued $400 million aggregate principal amount of senior unsecured notes, or the 2026 Notes, as described below, and used the proceeds from the 2018 Credit Facility and the 2026 Notes to repay in full the $1,178.1 million outstanding under the 2017 Credit Facility. For accounting purposes, pursuant to FASB ASC Topic 470, Debt, or ASC 470, these transactions were accounted for as an extinguishment of the 2017 Credit Facility. The Company recognized a loss on extinguishment of $35.4 million as a result, which was recorded in other (income) expense, net within the Company’s condensed consolidated statements of income during the year ended December 31, 2018.
The 2018 Term Loan B was issued to the lenders at a 0.25% discount, or $1.9 million. The Company incurred approximately $11.7 million of debt issuance costs in connection with the 2018 Credit Facility. The discount and debt issuance costs are recorded on the Company’s condensed consolidated balance sheet and are being amortized over the life of the 2018 Credit Facility using the effective-interest method.
On December 12, 2019, the Company amended the 2018 Credit Facility which, among other things, reduced the interest rate for borrowings under the 2018 Term Loan B from either the eurocurrency rate plus a margin of 3.25% or the base rate plus a margin of 2.25% to either the eurocurrency rate plus a margin of 2.75% or the base rate plus a margin of 1.75%. The Company incurred approximately $1.2 million of debt issuance costs in connection with the amendment. For accounting purposes, pursuant to ASC 470, this transaction was accounted for as a modification of the 2018 Credit Facility. The debt issuance costs were recognized in interest expense, net within the Company’s condensed consolidated statement of income during the year ended December 31, 2019.
12
On March 19, 2020, the Company amended the 2018 Credit Facility which, among other things, extended the maturity of both the 2018 Term Loan A and 2018 Revolving Credit Facility to the earlier of: (i) March 19, 2025 or (ii) September 15, 2023 if the outstanding principal on the 2024 Convertible Notes, as defined below, exceeds $350.0 million and the Company exceeds certain leverage ratios as of that date; increased borrowings under the 2018 Term Loan A from $234.4 million to a total of $264.8 million; increased the total available borrowing capacity under 2018 Revolving Credit Facility from $250.0 million to $282.5 million; and reduced the interest rate for borrowings under both the 2018 Term Loan A and 2018 Revolving Credit Facility from either the eurocurrency rate plus a margin of 3.00% or the base rate plus a margin of 2.00% to either the eurocurrency rate plus a margin of 2.50% or the base rate plus a margin of 1.50%. The Company incurred approximately $1.6 million of debt issuance costs in connection with the amendment. For accounting purposes, pursuant to ASC 470, this transaction was accounted for as a modification of the 2018 Credit Facility. Of the $1.6 million of debt issuance costs, approximately $1.1 million was recorded on the Company’s condensed consolidated balance sheet and is being amortized over the life of the 2018 Credit Facility using the effective-interest method, and approximately $0.5 million was recognized in interest expense, net within the Company’s condensed consolidated statement of income during the three months ended March 31, 2020.
Under the 2018 Credit Facility, borrowings under both the 2018 Term Loan A and 2018 Revolving Credit Facility bear interest at either the eurocurrency rate plus a margin of 2.50% or the base rate plus a margin of 1.50%. Borrowings under the 2018 Term Loan B bear interest at either the eurocurrency rate plus a margin of 2.75% or the base rate plus a margin of 1.75%. The eurocurrency rate is based on adjusted LIBOR and is subject to a floor of 0.00%. The base rate represents the highest of the Federal Funds Rate plus 0.50%, one-month adjusted LIBOR plus 1.00%, and the prime rate quoted by The Wall Street Journal, and is subject to a floor of 1.00%. The Company is required to pay a commitment fee on the 2018 Revolving Credit Facility of 0.35% per annum on the undrawn portion of the 2018 Revolving Credit Facility. Interest is due at least quarterly on amounts outstanding under the 2018 Credit Facility.
The 2018 Credit Facility requires the Company to comply with a leverage ratio. The 2018 Credit Facility also contains affirmative and negative covenants customary for financings of this type, including, among other things, limitations or prohibitions on repurchasing common shares, declaring and paying dividends and other distributions, redeeming and repurchasing certain other indebtedness, loans and investments, additional indebtedness, liens, mergers, asset sales and transactions with affiliates. In addition, the 2018 Credit Facility contains customary events of default. As of June 30, 2020 and December 31, 2019, the Company was in compliance with its debt covenants under the 2018 Credit Facility.
The 2018 Term Loan A and 2018 Term Loan B are payable in consecutive quarterly installments which began on December 31, 2018. In addition, beginning in 2020, the Company may be required to make mandatory prepayments towards the 2018 Term Loan B based on the Company’s consolidated leverage ratio and annual excess cash flows as defined under the terms of the 2018 Credit Facility. The Company is also permitted to make voluntary prepayments. Amounts outstanding under the 2018 Term Loan A may be voluntarily prepaid without premium or penalty, subject to customary breakage fees in connection with the prepayment of a eurocurrency loan. Under the amended 2018 Credit Facility, amounts voluntarily prepaid under the 2018 Term Loan B on or before June 12, 2020 will incur a prepayment premium of 1%; thereafter, amounts outstanding under the 2018 Term Loan B may be voluntarily prepaid without premium or penalty, subject to customary breakage fees in connection with the prepayment of a eurocurrency loan. These prepayments, if any, will be applied against remaining quarterly installments owed under the 2018 Term Loan A and 2018 Term Loan B in order of maturity with the remaining principal due upon maturity, unless directed otherwise by the Company. Based on the 2019 consolidated leverage ratio and excess cash flow calculation, both as defined under the terms of the 2018 Credit Facility, the Company was not required to make a mandatory prepayment in 2020 toward the 2018 Term Loan B.
As of June 30, 2020 and December 31, 2019, the weighted-average interest rate for borrowings under the 2018 Credit Facility was 3.86% and 5.52%, respectively.
During the six months ended June 30, 2020, the Company repaid a total amount of $10.4 million on amounts outstanding under the 2018 Credit Facility. During the six months ended June 30, 2019, the Company repaid a total amount of $10.0 million on amounts outstanding under the 2018 Credit Facility. As of June 30, 2020 and December 31, 2019, the U.S. dollar amount outstanding under the 2018 Credit Facility was $995.1 million and $975.0 million, respectively. Of the $995.1 million outstanding under the 2018 Credit Facility as of June 30, 2020, $258.2 million was outstanding under the 2018 Term Loan A and $736.9 million was outstanding under the 2018 Term Loan B. Of the $975.0 million outstanding under the 2018 Credit Facility as of December 31, 2019, $234.4 million was outstanding under the 2018 Term Loan A and $740.6 million was outstanding under the 2018 Term Loan B. There were no borrowings outstanding under the 2018 Revolving Credit Facility as of June 30, 2020 and December 31, 2019. There were no outstanding foreign currency borrowings under the 2018 Credit Facility as of June 30, 2020 and December 31, 2019.
13
During the three months ended June 30, 2020 and 2019, the Company recognized $8.9 million and $14.9 million, respectively, of interest expense relating to the 2018 Credit Facility, which included $0.1 million and $0.1 million, respectively, relating to non-cash interest expense relating to the debt discount and $0.5 million and $0.4 million, respectively, relating to amortization of debt issuance costs. During the six months ended June 30, 2020 and 2019, the Company recognized $21.2 million and $29.9 million, respectively, of interest expense relating to the 2018 Credit Facility, which included $0.1 million and $0.1 million, respectively, relating to non-cash interest expense relating to the debt discount and $0.9 million and $0.8 million, respectively, relating to amortization of debt issuance costs.
The fair value of the outstanding borrowings on the 2018 Term Loan A is determined by utilizing over-the-counter market quotes for similar instruments, which are considered Level 2 inputs as described in Note 12, Fair Value Measurements. As of June 30, 2020 and December 31, 2019, the carrying value of the 2018 Term Loan A was $257.0 million and $233.2 million, respectively, and the fair value was approximately $249.6 million and $235.7 million, respectively. The fair value of the outstanding borrowings under the 2018 Term Loan B is determined by utilizing over-the-counter market quotes, which are considered Level 2 inputs as described in Note 12, Fair Value Measurements. As of June 30, 2020 and December 31, 2019, the carrying amount of the 2018 Term Loan B was $729.0 million and $732.1 million, respectively, and the fair value was approximately $712.5 million and $744.8 million, respectively.
Convertible Senior Notes due 2019
In February 2014, the Company initially issued $1 billion aggregate principal amount of convertible senior notes, or the 2019 Convertible Notes, in a private offering to qualified institutional buyers, pursuant to Rule 144A under the Securities Act of 1933, as amended. The Company granted an option to the initial purchasers to purchase up to an additional $150 million aggregate principal amount of 2019 Convertible Notes which was subsequently exercised in full in February 2014, resulting in a total issuance of $1.15 billion aggregate principal amount of 2019 Convertible Notes. The 2019 Convertible Notes were senior unsecured obligations which ranked effectively subordinate to any of the Company’s existing and future secured indebtedness, including amounts outstanding under the 2018 Credit Facility, to the extent of the value of the assets securing such indebtedness. The 2019 Convertible Notes paid interest at a rate of 2.00% per annum payable semiannually in arrears on February 15 and August 15 of each year, beginning on August 15, 2014. Unless earlier repurchased or converted, the 2019 Convertible Notes matured on August 15, 2019. The Company could not redeem the 2019 Convertible Notes prior to their stated maturity date. Upon conversion, the 2019 Convertible Notes were to be settled in cash and, if applicable, the Company’s common shares, based on the applicable conversion rate at such time. The 2019 Convertible Notes had an initial conversion rate of 23.1816 common shares per $1,000 principal amount of the 2019 Convertible Notes, or an initial conversion price of approximately $43.14 per common share.
The Company incurred approximately $26.6 million of issuance costs during the first quarter of 2014 relating to the issuance of the 2019 Convertible Notes. Of the $26.6 million issuance costs incurred, $21.5 million and $5.1 million were recorded as debt issuance costs and additional paid-in capital, respectively, in proportion to the allocation of the proceeds of the 2019 Convertible Notes. The $21.5 million of debt issuance costs recorded on the Company’s condensed consolidated balance sheet were amortized over the contractual term of the 2019 Convertible Notes using the effective-interest method.
In February 2014, the $1.15 billion aggregate principal amount of the 2019 Convertible Notes were initially allocated between long-term debt, or liability component, and additional paid-in capital, or equity component, within the Company’s condensed consolidated balance sheet at $930.9 million and $219.1 million, respectively. The liability component was measured using the nonconvertible debt interest rate. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the face value of the 2019 Convertible Notes as a whole. Since the Company was required to settle these 2019 Convertible Notes at face value at or prior to maturity, this liability component was accreted up to its face value resulting in additional non-cash interest expense being recognized within the Company’s condensed consolidated statements of income while the 2019 Convertible Notes remained outstanding. The effective-interest rate on the 2019 Convertible Notes was approximately 6.2% per annum. The equity component was not to be remeasured as long as it continued to meet the conditions for equity classification.
14
In March 2018, the Company issued $550 million aggregate principal amount of new convertible senior notes due 2024, or 2024 Convertible Notes as described below, and subsequently used the proceeds, along with cash on hand, to repurchase $475.0 million of its existing 2019 Convertible Notes from a limited number of holders in privately negotiated transactions for an aggregate purchase price of $583.5 million, which included $1.0 million of accrued interest. For accounting purposes, pursuant to ASC 470, these transactions were accounted for as an extinguishment of 2019 Convertible Notes and an issuance of new 2024 Convertible Notes. The Company allocated the purchase price between the fair value of the liability component and the equity component of the 2019 Convertible Notes at $459.4 million and $123.0 million, respectively. As a result, the Company recognized $446.4 million as a reduction to long-term debt representing the carrying value of the liability component and $123.0 million as a reduction to additional paid-in capital representing the equity component of the repurchased 2019 Convertible Notes. The $13.1 million difference between the fair value and carrying value of the liability component of the repurchased 2019 Convertible Notes was recognized as a loss on extinguishment of debt as a result of the transaction and was recorded in other (income) expense, net within the Company’s condensed consolidated statement of income during the year ended December 31, 2018. The accounting impact of the 2024 Convertible Notes is described in further detail below.
On August 15, 2019, the 2019 Convertible Notes matured and the Company repaid the $675.0 million outstanding principal in cash, as well as $6.7 million of accrued interest.
During the three months ended June 30, 2019, the Company recognized $10.9 million of interest expense relating to the 2019 Convertible Notes, which included $6.8 million relating to non-cash interest expense relating to the debt discount and $0.6 million relating to amortization of debt issuance costs. During the six months ended June 30, 2019, the Company recognized $21.6 million of interest expense relating to the 2019 Convertible Notes, which included $13.5 million relating to non-cash interest expense relating to the debt discount and $1.3 million relating to amortization of debt issuance costs.
In conjunction with the issuance of the 2019 Convertible Notes, during February 2014, the Company paid approximately $685.8 million to enter into prepaid forward share repurchase transactions, or the Forward Transactions, with certain financial institutions, and paid approximately $123.8 million to enter into capped call transactions with respect to its common shares, or the Capped Call Transactions, with certain financial institutions. Subsequently, in conjunction with the repurchase of a portion of the 2019 Convertible Notes, during March 2018, the Company entered into agreements with the option counterparties to the Capped Call Transactions to terminate a portion of such existing transactions. See Note 10, Shareholders’ Deficit, for additional discussion on the Forward Transactions and Capped Call Transactions entered into in conjunction with the issuance of these 2019 Convertible Notes.
Convertible Senior Notes due 2024
In March 2018, the Company issued $550 million aggregate principal amount of convertible senior notes, or the 2024 Convertible Notes, in a private offering to qualified institutional buyers, pursuant to Rule 144A under the Securities Act of 1933, as amended. The 2024 Convertible Notes are senior unsecured obligations which rank effectively subordinate to any of the Company’s existing and future secured indebtedness, including amounts outstanding under the 2018 Credit Facility, to the extent of the value of the assets securing such indebtedness. The 2024 Convertible Notes pay interest at a rate of 2.625% per annum payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2018. Unless redeemed, repurchased or converted in accordance with their terms prior to such date, the 2024 Convertible Notes mature on March 15, 2024. Holders of the 2024 Convertible Notes may convert their notes at their option under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending June 30, 2018, if the last reported sale price of the Company’s common shares for at least 20 trading days (whether or not consecutive) in a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter exceeds 130% of the conversion price for the 2024 Convertible Notes on each applicable trading day; (ii) during the five business-day period immediately after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of 2024 Convertible Notes for each trading day of that measurement period was less than 98% of the product of the last reported sale price of the Company’s common shares and the conversion rate for the 2024 Convertible Notes for each such day; (iii) if the Company calls the 2024 Convertible Notes for redemption; or (iv) upon the occurrence of specified corporate events. On and after December 15, 2023, holders may convert their 2024 Convertible Notes at any time, regardless of the foregoing circumstances. Upon conversion, the 2024 Convertible Notes will be settled, at the Company’s election, in cash, the Company’s common shares, or a combination thereof, based on the applicable conversion rate at such time. The 2024 Convertible Notes had an initial conversion rate of 16.0056 common shares per $1,000 principal amount of the 2024 Convertible Notes, or an initial conversion price of approximately $62.48 per common share. The conversion rate is subject to adjustment upon the occurrence of certain events and was 16.0352 common shares per $1,000 principal amount of the 2024 Convertible Notes, or a conversion price of approximately $62.36 per common share, as of June 30, 2020.
15
The Company incurred approximately $12.9 million of issuance costs during the first quarter of 2018 relating to the issuance of the 2024 Convertible Notes. Of the $12.9 million issuance costs incurred, $9.6 million and $3.3 million were recorded as debt issuance costs and additional paid-in capital, respectively, in proportion to the allocation of the proceeds of the 2024 Convertible Notes. The $9.6 million of debt issuance costs, which was recorded as an additional debt discount on the Company’s condensed consolidated balance sheet, are being amortized over the contractual term of the 2024 Convertible Notes using the effective-interest method.
In March 2018, the $550 million aggregate principal amount of the 2024 Convertible Notes were initially allocated between long-term debt, or liability component, and additional paid-in-capital, or equity component, within the Company’s condensed consolidated balance sheet at $410.1 million and $139.9 million, respectively. The liability component was measured using the nonconvertible debt interest rate. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the face value of the 2024 Convertible Notes as a whole. Since the Company must still settle these 2024 Convertible Notes at face value at or prior to maturity, this liability component will be accreted up to its face value resulting in additional non-cash interest expense being recognized within the Company’s condensed consolidated statements of income while the 2024 Convertible Notes remain outstanding. The effective-interest rate on the 2024 Convertible Notes is approximately 8.4% per annum. The equity component is not remeasured as long as it continues to meet the conditions for equity classification.
As of June 30, 2020, the outstanding principal on the 2024 Convertible Notes was $550.0 million, the unamortized debt discount and debt issuance costs were $101.2 million, and the carrying amount of the liability component was $448.8 million, which was recorded to long-term debt within the Company’s condensed consolidated balance sheet. As of December 31, 2019, the outstanding principal on the 2024 Convertible Notes was $550.0 million, the unamortized debt discount and debt issuance costs were $112.6 million, and the carrying amount of the liability component was $437.4 million, which was recorded to long-term debt within the Company’s condensed consolidated balance sheet. The fair value of the liability component relating to the 2024 Convertible Notes was approximately $478.3 million and $508.6 million as of June 30, 2020 and December 31, 2019, respectively.
During the three months ended June 30, 2020 and 2019, the Company recognized $9.4 million and $8.9 million, respectively, of interest expense relating to the 2024 Convertible Notes, which included $5.4 million and $4.9 million, respectively, relating to non-cash interest expense relating to the debt discount and $0.3 million and $0.4 million, respectively, relating to amortization of debt issuance costs. During the six months ended June 30, 2020 and 2019, the Company recognized $18.6 million and $17.7 million, respectively, of interest expense relating to the 2024 Convertible Notes, which included $10.7 million and $9.8 million, respectively, relating to non-cash interest expense relating to the debt discount and $0.7 million and $0.7 million, respectively, relating to amortization of debt issuance costs.
Senior Notes due 2025
In May 2020, the Company issued $600 million aggregate principal amount of senior notes, or the 2025 Notes, in a private offering in the United States to qualified institutional buyers, pursuant to Rule 144A under the Securities Act of 1933, as amended, and outside the United States pursuant to Regulation S under the Securities Act of 1933, as amended. The 2025 Notes are senior unsecured obligations which rank effectively subordinate to any of the Company’s existing and future secured indebtedness, including amounts outstanding under the 2018 Credit Facility, to the extent of the value of the assets securing such indebtedness. The 2025 Notes pay interest at a rate of 7.875% per annum payable semiannually in arrears on March 1 and September 1 of each year, beginning on March 1, 2021. The 2025 Notes mature on September 1, 2025.
At any time prior to September 1, 2022, the Company may redeem all or part of the 2025 Notes at a redemption price equal to 100% of their principal amount, plus a “make whole” premium as of the redemption date, and accrued and unpaid interest to the redemption date. In addition, at any time prior to September 1, 2022, the Company may redeem up to 40% of the aggregate principal amount of the 2025 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 107.875%, plus accrued and unpaid interest. Furthermore, at any time on or after September 1, 2022, the Company may redeem all or part of the 2025 Notes at the following redemption prices, expressed as percentages of principal amount, plus accrued and unpaid interest thereon to the redemption date, if redeemed during the twelve-month period beginning on September 1 of the years indicated below:
|
|
Percentage |
|
2022 |
|
|
103.938 |
% |
2023 |
|
|
101.969 |
% |
2024 and thereafter |
|
|
100.000 |
% |
16
The 2025 Notes contain customary negative covenants, including, among other things, limitations or prohibitions on restricted payments, incurrence of additional indebtedness, liens, mergers, asset sales and transactions with affiliates. In addition, the 2025 Notes contain customary events of default.
The Company incurred approximately $7.9 million of issuance costs during the second quarter of 2020 relating to the issuance of the 2025 Notes. The $7.9 million of debt issuance costs, which was recorded as a debt discount on the Company’s condensed consolidated balance sheet, are being amortized over the contractual term of the 2025 Notes using the effective-interest method.
As of June 30, 2020, the outstanding principal on the 2025 Notes was $600.0 million, the unamortized debt issuance costs were $7.7 million, and the carrying amount was $592.3 million, which was recorded to long-term debt within the Company’s condensed consolidated balance sheet. The fair value of the 2025 Notes was approximately $621.4 million as of June 30, 2020 and was determined by utilizing over-the-counter market quotes and yield curves, which are considered Level 2 inputs as defined in Note 12, Fair Value Measurements.
During both the three and six months ended June 30, 2020, the Company recognized $4.3 million of interest expense relating to the 2025 Notes, which included $0.1 million relating to amortization of debt issuance costs.
Senior Notes due 2026
In August 2018, the Company issued $400 million aggregate principal amount of senior notes, or the 2026 Notes, in a private offering in the United States to qualified institutional buyers, pursuant to Rule 144A under the Securities Act of 1933, as amended, and outside the United States pursuant to Regulation S under the Securities Act of 1933, as amended. The 2026 Notes are senior unsecured obligations which rank effectively subordinate to any of the Company’s existing and future secured indebtedness, including amounts outstanding under the 2018 Credit Facility, to the extent of the value of the assets securing such indebtedness. The 2026 Notes pay interest at a rate of 7.250% per annum payable semiannually in arrears on February 15 and August 15 of each year, beginning on February 15, 2019. The 2026 Notes mature on August 15, 2026.
At any time prior to August 15, 2021, the Company may redeem all or part of the 2026 Notes at a redemption price equal to 100% of their principal amount, plus a “make whole” premium as of the redemption date, and accrued and unpaid interest to the redemption date. In addition, at any time prior to August 15, 2021, the Company may redeem up to 40% of the aggregate principal amount of the 2026 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 107.250%, plus accrued and unpaid interest. Furthermore, at any time on or after August 15, 2021, the Company may redeem all or part of the 2026 Notes at the following redemption prices, expressed as percentages of principal amount, plus accrued and unpaid interest thereon to the redemption date, if redeemed during the twelve-month period beginning on August 15 of the years indicated below:
|
|
Percentage |
|
2021 |
|
|
103.625 |
% |
2022 |
|
|
101.813 |
% |
2023 and thereafter |
|
|
100.000 |
% |
The 2026 Notes contain customary negative covenants, including, among other things, limitations or prohibitions on restricted payments, incurrence of additional indebtedness, liens, mergers, asset sales and transactions with affiliates. In addition, the 2026 Notes contain customary events of default.
The Company incurred approximately $5.4 million of issuance costs during the third quarter of 2018 relating to the issuance of the 2026 Notes. The $5.4 million of debt issuance costs, which was recorded as a debt discount on the Company’s condensed consolidated balance sheet, are being amortized over the contractual term of the 2026 Notes using the effective-interest method.
As of June 30, 2020, the outstanding principal on the 2026 Notes was $400.0 million, the unamortized debt issuance costs were $4.4 million, and the carrying amount was $395.6 million, which was recorded to long-term debt within the Company’s condensed consolidated balance sheet. As of December 31, 2019, the outstanding principal on the 2026 Notes was $400.0 million, the unamortized debt issuance costs were $4.7 million, and the carrying amount was $395.3 million, which was recorded to long-term debt within the Company’s condensed consolidated balance sheet. The fair value of the 2026 Notes was approximately $403.1 million and $424.1 million as of June 30, 2020 and December 31, 2019, respectively, and was determined by utilizing over-the-counter market quotes and yield curves, which are considered Level 2 inputs as defined in Note 12, Fair Value Measurements.
17
During the three months ended June 30, 2020 and 2019, the Company recognized $7.4 million and $7.4 million, respectively, of int